ATE316089T1 - Isoindolderivate - Google Patents

Isoindolderivate

Info

Publication number
ATE316089T1
ATE316089T1 AT00955004T AT00955004T ATE316089T1 AT E316089 T1 ATE316089 T1 AT E316089T1 AT 00955004 T AT00955004 T AT 00955004T AT 00955004 T AT00955004 T AT 00955004T AT E316089 T1 ATE316089 T1 AT E316089T1
Authority
AT
Austria
Prior art keywords
oxygen atom
pharmaceutically acceptable
acceptable salt
hydrogen atoms
represent hydrogen
Prior art date
Application number
AT00955004T
Other languages
English (en)
Inventor
Toshio Nagase
Tomoharu Iino
Yoshiyuki Sato
Teruyuki Nishimura
Jun-Ichi Eiki
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Application granted granted Critical
Publication of ATE316089T1 publication Critical patent/ATE316089T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT00955004T 1999-08-25 2000-08-25 Isoindolderivate ATE316089T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23900499 1999-08-25

Publications (1)

Publication Number Publication Date
ATE316089T1 true ATE316089T1 (de) 2006-02-15

Family

ID=17038474

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00955004T ATE316089T1 (de) 1999-08-25 2000-08-25 Isoindolderivate

Country Status (7)

Country Link
US (2) US6608098B1 (de)
EP (1) EP1207161B1 (de)
AT (1) ATE316089T1 (de)
AU (1) AU6729600A (de)
CA (1) CA2382528A1 (de)
DE (1) DE60025616T2 (de)
WO (1) WO2001014386A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
WO2002066479A1 (en) * 2001-02-23 2002-08-29 Banyu Pharmaceutical Co.,Ltd. Novel isoindole derivatives
GB0121709D0 (en) * 2001-09-07 2001-10-31 Imp College Innovations Ltd Food inhibition agent
BR0212985A (pt) 2001-09-24 2005-08-30 Imp College Innovations Ltd Uso de pyy ou de um agonista do mesmo na preparação de medicamentos para tratamento de distúrbios associados com excesso de peso
US8058233B2 (en) * 2002-01-10 2011-11-15 Oregon Health And Science University Modification of feeding behavior using PYY and GLP-1
CA2472882A1 (en) 2002-01-10 2003-07-17 Imperial College Innovations Ltd Use of pyy and glp-1, or an agonist thereof, for the modification of feeding behaviour
GB0300571D0 (en) 2003-01-10 2003-02-12 Imp College Innovations Ltd Modification of feeding behaviour
KR20060127909A (ko) * 2003-12-24 2006-12-13 비오타 사이언티픽 매니지먼트 피티와이 엘티디 호흡기 다핵체 바이러스 감염 치료용 다환 물질
MX2007010318A (es) 2005-02-25 2007-10-17 Irm Llc Compuestos y composiciones que contienen espiro como moduladores de los receptores nucleares de hormonas esteroideas.
GB0511986D0 (en) * 2005-06-13 2005-07-20 Imp College Innovations Ltd Novel compounds and their effects on feeding behaviour
TWI423972B (zh) 2006-09-28 2014-01-21 Biota Scient Management 治療呼吸系融合細胞病毒感染之多環劑
TWI428346B (zh) 2006-12-13 2014-03-01 Imp Innovations Ltd 新穎化合物及其等對進食行為影響
TWI508968B (zh) 2010-02-08 2015-11-21 Biota Scient Management 用於治療呼吸道融合性病毒感染的化合物
US8796303B2 (en) 2010-11-26 2014-08-05 Biota Scientific Management Pty Ltd. Imidazo[2,1-G][1,7]naphthyridines for treating respiratory syncytial virus infections
WO2012076966A1 (en) * 2010-12-10 2012-06-14 Lupin Limited Substituted thieno [3,4-b] pyrazine compounds
SG11201504594QA (en) 2012-12-19 2015-07-30 Novartis Ag Tricyclic compounds for inhibiting the cftr channel
MX2015007940A (es) 2012-12-19 2016-03-11 Novartis Ag Compuestos tricíclicos como inhibidores de cftr.
CN105418637A (zh) * 2015-12-08 2016-03-23 彭冬青 一种治疗甲亢的药物组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507863A (en) 1963-12-18 1970-04-21 Sandoz Ag Isoindolones and method for preparing same
US3928597A (en) 1974-08-15 1975-12-23 American Home Prod Hyperglycemia therapy
US4701208A (en) * 1983-08-02 1987-10-20 American Cyanamid Company Dihydroimidazopyrrolopyridine, quinoline, thieno- and furo[2,3-b]pyridine, dihydrothieno- and furo[2,3-b]-pyridine, thieno- and furo[3,2-b]pyridine and dihydrothieno- and furo[3,2-b]pyridine herbicides and method for preparation thereof
DE3520390A1 (de) 1984-07-07 1986-02-06 Bayer Ag, 5090 Leverkusen Imidazo-pyrrolo-pyridin-derivate
EP0183993A3 (de) 1984-11-16 1987-12-09 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft 2H-Imidazo[1',2':1,2]pyrrolo[3,4-b]pyridine und deren Verwendung als Unkrautbekämpfungsmittel
DE3674028D1 (de) 1985-03-12 1990-10-18 Ciba Geigy Ag Heterocyclisch kondensierte pyridin-verbindungen als herbizide.
US4717414A (en) 1986-08-08 1988-01-05 Ppg Industries, Inc. Herbicidally active imidazopyrrolo-pyridine (or benzene) derivatives
DE3634952A1 (de) 1986-10-14 1988-04-21 Bayer Ag Imidazo-pyrrolo-pyridin-derivate
JPS63295575A (ja) 1987-05-26 1988-12-01 Nissan Chem Ind Ltd イミダゾピロロピリジン誘導体、その製造法及び除草剤
EP0296109A3 (de) 1987-06-18 1989-12-20 Ciba-Geigy Ag 2-(Imidazolin-2-yl)nicotinsäurederivate
DE4108395A1 (de) 1991-03-15 1993-01-28 Boehringer Mannheim Gmbh Verwendung von oxazolo-(2,3-a)isoindol-und imidazo(2,1-a)-isoindol-derivaten als antivirale arzneimittel sowie neue oxazolo(2,3-a)isoindol-derivaten

Also Published As

Publication number Publication date
US6608098B1 (en) 2003-08-19
AU6729600A (en) 2001-03-19
US6777410B2 (en) 2004-08-17
US20040053923A1 (en) 2004-03-18
EP1207161A4 (de) 2002-10-30
EP1207161A1 (de) 2002-05-22
EP1207161B1 (de) 2006-01-18
CA2382528A1 (en) 2001-03-01
WO2001014386A1 (en) 2001-03-01
DE60025616T2 (de) 2006-11-30
DE60025616D1 (de) 2006-04-06

Similar Documents

Publication Publication Date Title
DE60025616D1 (de) Isoindolderivate
DK1221444T3 (da) Kondenserede imidazolforbindelser og lægemidler mod diabetes mellitus
NO20020968D0 (no) Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
DE69820248D1 (de) Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
DK1029853T3 (da) Heteroaromatiske bicykliske derivativer, der er egnede som anticancermidler
EP1008588A4 (de) 11,15-o-dialkylprostaglandin-e-derivate, verfahren zu ihrer herstellung und arzneimittel, die diese als aktiven inhaltsstoff enthalten
RU94036772A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования эндометриоза
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
NO20014925D0 (no) Farmasöytiske forbindelser
AU4396899A (en) Remedies for diabetes
PL359415A1 (en) Oxadiazole derivatives having anticancer effects
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
WO2003053971A8 (en) Pyridoquinoxaline antivirals
DE69814800D1 (de) Epoxysuccinamid-derivate oder ihre salze
NO323556B1 (no) Forbindelser, farmasoytiske preparater som omfatter forbindelsene, og anvendelse av forbindelsene ved fremstilling av antibakterielle medikamenter.
AU2408602A (en) Indole derivatives and use thereof in medicines
IL169577A0 (en) Oligosaccharide derivatives and pharmaceutical compostions containing the same
NO993911L (no) Remedier/Forebygningsmidler for Õndedrettssykdommer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties